Document is current
Any future updates will be listed below
-
Authors
Ingle, James N. https://orcid.org/0000-0003-1257-7731
Suman, Vera J.
Solanki, Malvika H.
Passow, Marie R.
Campbell, Jordan D.
Wang, Liewei
Goetz, Matthew P.
-
Funding
Funding for this research was provided by:
United States National Institutes of Health (P50CA116201, P50CA116201, P50CA116201, P50CA116201)
Breast Cancer Research Foundation (BCRF 22-076, BCRF 22-076)
the George M. Eisenberg Foundation for Charities (No grant ID, No grant ID, No grant ID, No grant ID, No grant ID, No grant ID)
the Nan Sawyer Breast Cancer Fund (No grant ID)
- License Information
-
More Information
Article History
Received: 19 September 2024
Accepted: 27 February 2025
First Online: 19 March 2025
Declarations
:
: This study was performed consistent with the principles of the Declaration of Helsinki. Approval was granted by the Mayo Clinic Institutional Review Board.
: Not applicable.
: LW reports that she is a co-founder and stockholder in OneOme, LLC; MPG reports personal fees for CME activities from Research to Practice, Clinical Education Alliance, Medscape, and MJH Life Sciences; personal fees serving as a panelist for a panel discussion from Total Health Conferencing and personal fees for serving as a moderator for Curio Science; personal fees from Ideology; consulting fees to Mayo Clinic from ARCTherapeutics, AstraZeneca, Biotheranostics, Blueprint Medicines, Lilly, Rna Diagnostics, Sanofi Genzyme, Seattle Genetics and Engage Health Media; and grant funding to Mayo Clinic from Lilly, Pfizer, Sermonix, Loxo, AstraZeneca and ATOSSA. The other authors declare no financial interests.
